Cargando…
Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040
SIMPLE SUMMARY: The nitric oxide donor, NCX4040, a non-steroidal anti-inflammatory-NO donor, is cytotoxic to a number of human tumors, including ovarian tumors cells. It has been shown to be safe in vivo. While the precise mechanism of action of NCX4040 is not clear at this time, NCX4040 has been re...
Autores principales: | Sinha, Birandra K., Tokar, Erik J., Li, Jianying, Bushel, Pierre R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818835/ https://www.ncbi.nlm.nih.gov/pubmed/36612280 http://dx.doi.org/10.3390/cancers15010285 |
Ejemplares similares
-
Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells
por: Sinha, Birandra K., et al.
Publicado: (2022) -
Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy
por: Sinha, Birandra K., et al.
Publicado: (2023) -
Exploring NCX4040, an Aspirin Derivative, as a Potential Treatment for Benign Prostatic Hyperplasia
por: Shahagadkar, Preksha Vaibhav, et al.
Publicado: (2021) -
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
por: Tesei, Anna, et al.
Publicado: (2005) -
NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells
por: Sinha, Birandra K., et al.
Publicado: (2021)